Hon Maylouisa Noel Hill, Liberia’s Assistant Minister for New Media and National Branding, Executive Mayor of the City of Johannesburg, Mr Dada Morero (who will join us later in the programme), President of BUSA and Co-Chair of B20, Mr Mxolisi Mgojo, …
I would like to begin by officially thanking all the Ministers, Deputy Ministers, Senior Government Officials, the South African Embassy and all our counterparts for making this short visit a great success. The past three days have been very busy with the …
SCOTTSDALE, Ariz., March 19, 2025 (GLOBE NEWSWIRE) -- Journey Medical Corporation (“Journey Medical” or the “Company”) (Nasdaq: DERM), a commercial-stage pharmaceutical company that primarily focuses on selling and marketing U.S. Food and Drug …
MIDLAND, Texas, March 19, 2025 (GLOBE NEWSWIRE) -- Diamondback Energy, Inc. (NASDAQ: FANG) (“Diamondback”), today announced that it plans to release first quarter 2025 financial results on May 5, 2025 after the market closes. In connection with the …
SPRINGFIELD, Mo., March 19, 2025 (GLOBE NEWSWIRE) -- The Board of Directors of Great Southern Bancorp, Inc. (NASDAQ:GSBC), the holding company for Great Southern Bank, declared a $0.40 per common share dividend for the first quarter of the calendar year …
MIDLAND, Texas, March 19, 2025 (GLOBE NEWSWIRE) -- Viper Energy, Inc. (NASDAQ: VNOM) (“Viper”), a subsidiary of Diamondback Energy, Inc. (NASDAQ: FANG) (“Diamondback”), today announced that it plans to release first quarter 2025 financial results on May 5, …
scPharmaceuticals generated fourth quarter 2024 net FUROSCIX® revenue of $12.2 million, and full year 2024 revenue of $36.3 million Cash and cash equivalents of $75.7 million as of December 31, 2024 U.S. Food and Drug Administration (FDA) approved the …
– Total Revenues increased 30.8% for the quarter over the prior year period to $51.7 million – – Total Written Premium increased 20.0% for the quarter over the prior year period to $361.4 million – – Organic Revenue Growth Rate* of 20.5% for the quarter – …
SOUTH SAN FRANCISCO, Calif., March 19, 2025 (GLOBE NEWSWIRE) -- Corvus Pharmaceuticals, Inc. (NASDAQ: CRVS), a clinical-stage biopharmaceutical company, today announced that members of its leadership team will conduct one-on-one meetings with investors and …
Preclinical pipeline re-prioritization to focus on four potentially transformative programs to advance toward clinic, led by CNTY-308 in B-cell mediated autoimmune diseases and malignancies New concentrated clinical focus for CNTY-101 based on unique …
Net Sales Increase of 7.8% for Q4 and 10.4% for Fiscal 2024 ex the 53rd week GAAP Diluted EPS of $3.39 for Q4 and $4.60 for Fiscal 2024 Adjusted Diluted EPS of $3.48 for Q4 and $5.04 for Fiscal 2024 PHILADELPHIA, PA, March 19, 2025 (GLOBE NEWSWIRE) -- Five …
NASHUA, N.H., March 19, 2025 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD) ("iCAD" or the "Company") a global leader on a mission to create a world where cancer can’t hide by providing clinically proven AI-powered breast health …
BOSTON, March 19, 2025 (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a global commercial-stage biopharmaceutical company focused on transforming the lives of patients living with rare neuroendocrine diseases, today announced it has …
CAMBRIDGE, Mass., March 19, 2025 (GLOBE NEWSWIRE) -- Akebia Therapeutics®, Inc. (“Akebia”) (Nasdaq: AKBA), a biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease, today announced that it has commenced an …
WASHINGTON, DC, UNITED STATES, March 19, 2025 /EINPresswire.com/ -- The Data Foundation today released its first "Evidence Capacity Pulse Report" documenting substantial changes affecting America's data and evaluation infrastructure …
Publishing Innovator Highlights the Power of Storytelling and Connection BEVERLY HILLS, CA, UNITED STATES, March 19, 2025 /EINPresswire.com/ -- Andréa Albright, Founder and CEO of Beverly Hills Publishing™, has been featured on the cover of …
Métis Crossing Knowledge Holder recognized for exceptional service and commitment to sharing Métis culture SMOKY LAKE, ALBERTA, CANADA, March 19, 2025 /EINPresswire.com/ -- Métis Crossing is proud to celebrate Lilyrose Meyers, the recipient of …
Daix (France), New York City (New York, United States), March 19, 2025 – Inventiva (Euronext Paris and NASDAQ: IVA) (“Inventiva” or the “Company”), a clinical-stage biopharmaceutical company focused on the development of oral small molecule therapies for …
Daix (France), New York City (New York, Etats-Unis), le 19 mars 2025 – Inventiva (Euronext Paris et NASDAQ : IVA) (« Inventiva » ou la « Société »), société biopharmaceutique spécialisée dans le développement clinique de petites molécules administrées par …
NEW YORK, March 19, 2025 (GLOBE NEWSWIRE) -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Maravai LifeSciences Holdings, Inc. (“ …
